Johnson & Johnson Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-08-02
Share capital
39,751,500.00 PLN
Registered address
Iłżecka 24, 02-135 Warszawa, Poland

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 361 days for 2022). All were audited by a statutory auditor.

  • 2025not filed
  • 202411/06/2026
  • 202314/01/2025
  • 202210/07/2024
  • 202128/11/2022
  • 202022/12/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue
This companyUSD 194.33mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 8.50mMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 179.63mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 97.21mMedianUSD 608.93kAverageUSD 11.85m

Public procurement

1353 tenders recorded as contractor: 487 national ($19,775,143) and 866 EU ($1,706,480,340).

SubjectAmount
DEZP.261.14.2026 “Supply of disposable equipment, implants and ophthalmic materials.”
$99,103
Purchase and delivery of dressings and surgical drapes, together with equipment lease (for lots 34 and 35), for the current needs of Uniwersytecki Szpital Kliniczny w Opolu.
$312K
Supply of medicinal products and medical devices
$121.6K

Trademarks

Johnson & Johnson Poland currently holds no active trademarks with the Polish Patent Office. 9 marks have expired or were not registered. The first mark was filed in 2001.

MarkNumberClassesStatusProtected until
Misioterapia(word)Z.3847171, 3, 5, 9, 10, 16, 21, 35, 36, 41, 42, 44Not registered –
Poddaj się wiosennej obsesji zakupów(word)Z.2926655, 41Refused –
ZDROWE PIĘKNO(word)Z.2583773, 5Proceedings discontinued –
Neutrogena PIĘKNO I PIELĘGNACJA TWOJEJ SKÓRY(word)Z.2505233, 5Proceedings discontinued –
Neutrogena PIĘKNO I PIELĘGNACJA(word)Z.2505253, 5Proceedings discontinued –
MarkProtected until
Misioterapia(word)–
Poddaj się wiosennej obsesji zakupów(word)–
ZDROWE PIĘKNO(word)–
Neutrogena PIĘKNO I PIELĘGNACJA TWOJEJ SKÓRY(word)–
Neutrogena PIĘKNO I PIELĘGNACJA(word)–

Authorized Representatives

Artur Rosa – Management Board Member
Dorota Barbara Dyba – Attorney-in-fact (sole)
Maciej Mikołaj Gierlotka – Attorney-in-fact (sole)
Michał Wojtysiak – Attorney-in-fact (sole)

Manner of representation

Each member of the management board acting independently is authorized to represent the company and make declarations on its behalf.

Ownership

OwnerSharesShare valueStake
Johnson & Johnson Health Care Systems Inc
795,030$10,737,844.41100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1995-03-07.

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Jun 23, 2022Merger registered
Jun 3, 2022Call to creditors
Jun 4, 2014Merger plan

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Novartis Polandsp. z o.o.
Bialmedsp. z o.o.
Servier Polska Servicessp. z o.o.
Stada Pharmsp. z o.o.
Olympus Polskasp. z o.o.
ITPS.A.
Orkla CareS.A.
Synkmedsp. z o.o.
Intimexsp. z o.o. + limited partnership
Mitramed Paweł Wysocki, Piotr Wachaczyksp. j.

Change history

DateEvent
2007-08-29Address change
2001-08-02Entered in the register

FAQ

Last updated: 2026-10-07